GreenSignal Bio Pharma Ltd IPO Message Board (Page 10)

QIB nil at 0300 pm now what about the issue??? whether the issue cancelled

Sensex 27500 ( - 600 ) = 26900

Nifty 8525 ( - 200 ) = 8325

Other Index

Auto ( - 4.5 % )
Finance & FMCG ( - 3 % )
Realty ( - 5 % )
Consumer durables ( - 5 % )

All other indes minimum 2 % down

What''s going on ?

.

Listing range 57 - 60

So the issue looks not going through price reduction on cards

any good stock u buy now ?

Septa sir, i bought wipro 200 shares at 460rs ..please tell me should i hold ? When it will rise?

QIB : 0.00
NII : 0.086
RII : 5.23

Overall : 0.54

It is looking like the IPO WON''T get through based on QIB nos... I don''t think I have seen a case where RIIs have gotten subscribed this high & QIB is NIL!

The story may be good and so may be the future prospects. But the pricing is way too high.

Retailers who have applied at 76 , also will be allotted .

They are going to be '' bali ka bakra "

Abhi kuch umeed hai ya yeah IPO gaya

No Anchor Investors the day before issue opens.

That means

Red Signal 4 Green Signal

.

is this the first IPO where QIBs subscription is zero before 30 mins closing time ?

This is SME IPO going to be listed in T group.

Fair value of 10 rupee share is 12 rupees & the Company Promoters , Private Equity , venture Capitalist & High Networth Investors want to exit at 76-80 rupees

Till 2 : 30 pm , QIBs/FIIs not opened their A/C yet

They are very bearish , busy in selling

Nifty 200 down Sensex 550 down

Latest subscription ????

Industry Outlook
Vaccination is one of the most cost-effective public health tools to prevent infectious diseases. In recent decades, the number of privately owned firms active in the sector have grown rapidly. Their success in bringing low cost vaccine solutions to public vaccine markets is an important driver behind the emergence of the sector. Biotechnology can be classified into two broad categories: R&D and discovery of new services and new products in Biological Sciences and Industrial Processes. Vaccine comes under Biotech umbrella.

The year-on-year growth of the biotech market is expected to accelerate, driven by high demand for vaccines, bio pesticides, bio fertilizers, bio diesel, bio therapeutics and medical devices in India as well as at the global level. India’s biotech sector is currently valued at over USD 7 bn, having grown at a CAGR of 20 per cent over the last decade. India is a world leader in vaccines, producing nearly 60 percent of the world’s supply.

Company Outlook
GreenSignal Bio Pharma is engaged in manufacturing of BCG vaccine and BCG-ONCO and caters to a niche product profile with global presence. Both drugs are generic drugs and do not require any patents for the same. BCG vaccine is used for immunisation against Tuberculosis. BCG-ONCO is used as a immunotherapy drug in the treatment of urinary bladder cancer. GreenSignal is WHO prequalified to supply the BCG vaccine to UNICEF. It has a long-term contract with UNICEF. It also includes other clients like Indonesia, Nepal and Ministry of Health, India.

GreenSignal Pharma business has been organised into domestic and international operations. GreenSignal''s domestic and international operations accounted for 53.79 per cent and 46.20 per cent, respectively of its net revenues from operations, for FY16. The company is a low cost producer of the vaccine. India is one of the major suppliers of vaccines for UNICEF programs with the value exceeding 1 crore. Company intends to market its product BCG-ONCO in international markets. It also plans to add a new vaccine to its product portfolio with expanding its geographies.

It has only two products in its portfolio and BCG vaccine contributes to 95 per cent of the revenue. If there is any impediment in its domestic or overseas sales, it can adversely affect its business and profits. Company revenue cycle has witnessed ups and downs in last five years with one year in profit. Continuous losses can affect its sustainability and overall operation. It has underutilised capacity at 48.63 per cent as of FY16.

How can I cancell my application?? I have applied through SBI. Now edit option is not available.

i applied for 2 application .
tell me about GSBP company.
any Grey premium.
it''s a T group comp.?

FII SELLING BEST TO AVOID IF SUB LESS THAN 15 TIMES

we should apply
this could be a multibagger
higher the risk, higher the returns

HNI will enter after 2pm

Till 2 PM

Subscription still < 50 % , Only Retailers

Better to avoid

May hit lower circuit on listing

Latest subscription pls

Greensignal Bio Pharma IPO

Day 3 at 2:00P.M.
QIB : 0.00×
NII : 0.04×
RET : 4.43×
TOTAL : 0.45×

Note:
If QIB portion is under-subscribed then the issue not cannot go through ...

Thanks

Latest subscription ????

Qib subscription ?????????